Quanta Dialysis Technologies Limited, a pioneering name in the renal care industry, is headquartered in Great Britain. Founded in 2012, the company has rapidly established itself as a leader in innovative dialysis solutions, focusing on home and hospital-based treatments. Quanta's flagship product, the SC+ dialysis system, stands out for its compact design and user-friendly interface, enabling greater patient autonomy and improved quality of life. With a commitment to advancing renal care, Quanta operates across Europe and is expanding its reach globally. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Quanta Dialysis Technologies is dedicated to transforming the dialysis experience, making it more accessible and efficient for patients worldwide.
How does Quanta Dialysis Technologies Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Quanta Dialysis Technologies Limited's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Quanta Dialysis Technologies Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that Quanta Dialysis Technologies may not yet have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. As the industry increasingly prioritises climate action, it will be essential for the company to consider developing measurable targets and strategies to align with global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Quanta Dialysis Technologies Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
